CSL-689

DB17726InvestigationalProtein Based Therapies

CSL689 is a recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP).

Mechanism: Pharmacologically active on Coagulation factor VII
Curator reviewed
Also known as: rVIIa-FP
Code names: CSL-689

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with CSL-689, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.